CANF
Price:
$0.339
Market Cap:
$15.87M
Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction. The company's lead drug candidate Piclidenoson, which has been completed Phase III clinical trial for the treatment of psoriasis; and Phase II clinical trial for the treatment of COVID-19. It also develops Namodenoson that is in Phase III clinical trial for the treatment of hepatocellular carcinoma, as well as in Phase IIb trial for the treatment of non-alcoholic steatohepatitis; and CF602, which is in pre-clinical trial for the treatment of erectile dysfunction. In addition, the company develops ...[Read more]
Industry
Biotechnology
IPO Date
2012-11-06
Stock Exchange
AMEX
Ticker
CANF
According to Can-Fite BioPharma Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 9.51M. This represents a change of -4.61% compared to the average of 9.97M of the last 4 quarters.
The mean historical Enterprise Value of Can-Fite BioPharma Ltd. over the last ten years is 14.65M. The current 9.51M Enterprise Value has changed 6.39% with respect to the historical average. Over the past ten years (40 quarters), CANF's Enterprise Value was at its highest in in the June 2021 quarter at 37.43M. The Enterprise Value was at its lowest in in the June 2019 quarter at -913294.05.
Average
14.65M
Median
15.59M
Minimum
5.26M
Maximum
25.42M
Discovering the peaks and valleys of Can-Fite BioPharma Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 94.09%
Maximum Annual Enterprise Value = 25.42M
Minimum Annual Increase = -67.50%
Minimum Annual Enterprise Value = 5.26M
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 6.63M | 26.00% |
| 2023 | 5.26M | -63.06% |
| 2022 | 14.24M | -18.36% |
| 2021 | 17.44M | 34.84% |
| 2020 | 12.94M | 94.09% |
| 2019 | 6.66M | -67.50% |
| 2018 | 20.50M | 0.15% |
| 2017 | 20.47M | -19.45% |
| 2016 | 25.42M | 49.98% |
| 2015 | 16.95M | -22.20% |
The current Enterprise Value of Can-Fite BioPharma Ltd. (CANF) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
8.71M
5-year avg
11.30M
10-year avg
14.65M
Can-Fite BioPharma Ltd.’s Enterprise Value is less than Kazia Therapeutics Limited (29.72M), greater than CNS Pharmaceuticals, Inc. (-6092778.00), greater than Clearmind Medicine Inc. (-3714308.00), less than Soligenix, Inc. (11.75M), greater than GRI Bio, Inc. (356.75K), greater than Oragenics, Inc. (4.58M), greater than Silo Pharma, Inc. (-324685.00), greater than Biodexa Pharmaceuticals Plc (-1171483.62), less than Jaguar Health, Inc. (30.76M), greater than Calidi Biotherapeutics, Inc. (3.78M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 29.72M | $21.67M | |
| -6092778.00 | $3.74M | |
| -3714308.00 | $722.23K | |
| 11.75M | $16.43M | |
| 356.75K | $5.38M | |
| 4.58M | $3.55M | |
| -324685.00 | $3.59M | |
| -1171483.62 | $3.15M | |
| 30.76M | $2.39M | |
| 3.78M | $11.04M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Can-Fite BioPharma Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Can-Fite BioPharma Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Can-Fite BioPharma Ltd.'s Enterprise Value?
What is the highest Enterprise Value for Can-Fite BioPharma Ltd. (CANF)?
What is the 3-year average Enterprise Value for Can-Fite BioPharma Ltd. (CANF)?
What is the 5-year average Enterprise Value for Can-Fite BioPharma Ltd. (CANF)?
How does the current Enterprise Value for Can-Fite BioPharma Ltd. (CANF) compare to its historical average?